Drug Discovery News
-
Korea's GI Innovation inks MoU with Merck for bio drug development
Drug Discovery | News | 0 Comment | 10 Nov, 2021
South Korea-based GI Innovation has inked a biopharmaceutical manufacturing and development based Memorandum o...Read more
-
AUM Biosciences raises $27M “Series A” fund to advance precision cancer therapies
Drug Discovery | News | 0 Comment | 13 Oct, 2021
Singapore's AUM Biosciences (AUM) has completed of $27 million series A funding round to develop a drug pipeline focused...Read more
-
Israel's CytoReason introduces AI clinical drug development platform to Japan’s pharma market
Drug Discovery | News | 0 Comment | 30 Sep, 2021
CytoReason, an AI company developing computational disease models for discovery and clinical drug development, and Summi...Read more
-
Japan sets eyes on rare pediatric liver diseases
Drug Discovery | News | 0 Comment | 22 Sep, 2021
US-based Mirum Pharmaceuticals, Inc. and Japanese firm Takeda Pharmaceutical have entered into an exclusive licensing ag...Read more
-
Drug Discovery | News | 0 Comment | 17 Sep, 2021
SuperTrans Medical ("STM"), an Australian biopharmaceutical company developing novel antibiotics that target difficult-t...Read more
-
BC Platforms to enable longitudinal RWD and Genomics access for drug development in Africa
Drug Discovery | News | 0 Comment | 13 Sep, 2021
BC Platforms (BCP), a global leader in genomics research, analytics and global data access, announced a new collabo...Read more
-
French firm Poxel launches type 2 diabetes drug in Japan
Drug Discovery | News | 0 Comment | 10 Sep, 2021
French firm POXEL SA along with its partner, Sumitomo Dainippon Pharma, is launching TWYMEEG (Imeglimin hydro...Read more
-
Drug Discovery | Opinion | 4 Comment | 06 Sep, 2021
What unique initiatives are being taken by the company to connect microbiome with human health? Which are the major ther...Read more
-
Taiwan's Centre for Drug Evaluation initiates new drug trial against COVID-19
Drug Discovery | News | 1 Comment | 16 Aug, 2021
US-based Senhwa Biosciences, Inc. has announced that its novel oral drug, Silmitasertib, has been included in Taiwa...Read more
-
Healx’s AI-platform to create world’s most detailed rare disease biomedical knowledge graph
Drug Discovery | News | 1 Comment | 10 Aug, 2021
Healx, the AI-powered, UK-founded global drug discovery company, has entered a partnership with Japan's Ono Pharmace...Read more
-
Japan's Otsuka Pharma receives $17.8 M grant for TB drug trial
Drug Discovery | News | 1 Comment | 10 Aug, 2021
Otsuka Pharmaceutical Development & Commercialization, Inc., a subsidiary of Japan-based Otsuka Pharmaceutical, has ...Read more
-
Chinese firms to advance drug development for hard-to-drug molecular targets
Drug Discovery | News | 1 Comment | 09 Aug, 2021
Hong Kong's Antengene Corporation Limited, a biopharmaceutical company focused on hematology and oncology drugs is ...Read more
-
Chinese startups accelerate innovative drugs R&D for novel coronavirus
Drug Discovery | News | 1 Comment | 03 Aug, 2021
China-based startups Insilico Medicine and Westlake Pharma have announced a strategic partnership to jointly develop inn...Read more
-
Taiwan brings hope for breast cancer patients with new epigenetic drug
Drug Discovery | News | 1 Comment | 28 Jul, 2021
Currently, estrogen-receptor-positive breast cancer accounts for about 70% of all breast cancers, with hormone therapy (...Read more
-
China emphasizes on self-replicating, conventional mRNA therapeutics and vaccines
Drug Discovery | News | 1 Comment | 21 Jul, 2021
China-based Junshi Biosciences has established a joint venture with Immorna to develop and commercialize new drugs for t...Read more
-
Product launches by Asian pharma cos can benefit antiviral drug makers in APAC: Graphical Research
Drug Discovery | News | 0 Comment | 19 Jul, 2021
The global antiviral drugs market growth is stimulated by a growing focus toward therapeutic management ...Read more
-
Korean firm Celltrion’s mAb candidate effective against Delta variant
Drug Discovery | News | 0 Comment | 16 Jul, 2021
South Korean firm Celltrion Group has announced new results from an in vivo efficacy study showing that regdan...Read more
-
Adlai Nortye raises $100 M (Series D) to accelerate clinical and drug development programs
Drug Discovery | News | 0 Comment | 15 Jul, 2021
Adlai Nortye Ltd., a global biopharmaceutical company focused on developing innovative oncology drugs, has complete...Read more
